Introduction and Objective: The National Diabetes Prevention Program (NDPP) is an evidence-based lifestyle intervention that reduces the risk of type 2 diabetes. Over 3,000 organizations have adopted the NDPP, but over half have since discontinued services, often due to challenges with financial sustainability. To address problematic de-adoption of the NDPP, we examined organizations that have sustained program delivery over time to identify strategies that may be adopted by other programs. Methods: In this qualitative study, we interviewed 21 coordinators from organizations that had sustained NDPP delivery for five or more years and planned to continue delivery. Organizations were sampled to include all US regions and organization types. Interviews focused on implementation practices related to operations and financing. Data were analyzed thematically to identify successful strategies for financial sustainability. Results: Interviewees represented a range of settings: community-based organizations (n=9), healthcare organizations (n=8), local health departments (n=2), and universities (n=2). Organizations had delivered the NDPP for 8.5 years (SD=2.7) on average. Most relied on multiple financing strategies, including grant and institutional funding, billing third-party payers, self-pay options, and charitable donations. Only one organization described a program that was fully sustainable through billing alone. Cost-control strategies focused on low-cost recruitment channels, minimum group sizes, virtual delivery, reducing administrative overhead, and using volunteer and part-time coaches. Conclusion: Organizations can sustain NDPP delivery through multiple strategies for program financing and cost control. Despite expanding payer coverage, grant funding and in-kind support remain critical, highlighting the gap between reimbursement rates and delivery costs. These strategies may help other organizations strengthen and sustain access to the NDPP while reimbursement models continue to evolve. Disclosure N. Ritchie: None. M. Turk: None. Funding NIH (R15HL163736)
RITCHIE et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: